Biofrontera Inc.
BFRINext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for BFRI. That does not mean none is planned.
Get an email about BFRI's next catalysts
Track Biofrontera (BFRI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
BF-200 ALA gel
Actinic Keratosis
BF-200 ALA
Actinic Keratosis
methyl-aminolevulinate
Basal Cell Carcinoma (BCC)
MAL Cream
Actinic Keratosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BF-200 ALA gel | Phase 3 | Actinic Keratosis | - | - |
BF-200 ALA | Phase 3 | Actinic Keratosis | - | - |
methyl-aminolevulinate | Phase 3 | Basal Cell Carcinoma (BCC) | - | - |
MAL Cream | Phase 3 | Actinic Keratosis | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Biofrontera Inc.'s drug pipeline?β
CatalystAlert tracks 4 drug candidates in Biofrontera Inc.'s (BFRI) pipeline across Phase 3. Its lead program is BF-200 ALA (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Biofrontera Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Biofrontera Inc. (BFRI) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track BFRI biotech catalysts?β
Add BFRI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Biofrontera Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
